Hepatitis B / / Luis Rodrigo, editor.

Current pharmacologic therapies for chronic hepatitis B virus (HBV) infection allow viral suppression and normalization of the liver enzyme alanine aminotransferase (ALT) and prevent liver disease from progressing. The currently available antiviral therapies very rarely lead to a functional cure. Th...

Full description

Saved in:
Bibliographic Details
TeilnehmendeR:
Place / Publishing House:London : : IntechOpen,, 2022.
Year of Publication:2022
Language:English
Physical Description:1 online resource (126 pages)
Tags: Add Tag
No Tags, Be the first to tag this record!
id 993603750404498
ctrlnum (CKB)5850000000050400
(NjHacI)995850000000050400
(EXLCZ)995850000000050400
collection bib_alma
record_format marc
spelling Hepatitis B / Luis Rodrigo, editor.
London : IntechOpen, 2022.
1 online resource (126 pages)
text txt rdacontent
computer c rdamedia
online resource cr rdacarrier
Description based on publisher supplied metadata and other sources.
Current pharmacologic therapies for chronic hepatitis B virus (HBV) infection allow viral suppression and normalization of the liver enzyme alanine aminotransferase (ALT) and prevent liver disease from progressing. The currently available antiviral therapies very rarely lead to a functional cure. Thus, the future of a cure for HBV lies in triple combination therapies with concerted action on replication inhibition, antigen reduction, and immune stimulation. This book reviews the mechanisms and pathogenesis of HBV, as well as discusses current and potential future treatments.
Hepatoma.
Liver Tumors.
1-80355-008-2
Rodrigo, Luis, editor.
language English
format eBook
author2 Rodrigo, Luis,
author_facet Rodrigo, Luis,
author2_variant l r lr
author2_role TeilnehmendeR
title Hepatitis B /
spellingShingle Hepatitis B /
title_full Hepatitis B / Luis Rodrigo, editor.
title_fullStr Hepatitis B / Luis Rodrigo, editor.
title_full_unstemmed Hepatitis B / Luis Rodrigo, editor.
title_auth Hepatitis B /
title_new Hepatitis B /
title_sort hepatitis b /
publisher IntechOpen,
publishDate 2022
physical 1 online resource (126 pages)
isbn 1-80355-008-2
callnumber-first R - Medicine
callnumber-subject RC - Internal Medicine
callnumber-label RC280
callnumber-sort RC 3280 L5 H473 42022
illustrated Not Illustrated
dewey-hundreds 600 - Technology
dewey-tens 610 - Medicine & health
dewey-ones 616 - Diseases
dewey-full 616.99436
dewey-sort 3616.99436
dewey-raw 616.99436
dewey-search 616.99436
work_keys_str_mv AT rodrigoluis hepatitisb
status_str n
ids_txt_mv (CKB)5850000000050400
(NjHacI)995850000000050400
(EXLCZ)995850000000050400
carrierType_str_mv cr
is_hierarchy_title Hepatitis B /
author2_original_writing_str_mv noLinkedField
_version_ 1796653233191518208
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01439nam a2200289 i 4500</leader><controlfield tag="001">993603750404498</controlfield><controlfield tag="005">20230704203500.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr |||||||||||</controlfield><controlfield tag="008">230704s2022 enk o 000 0 eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5850000000050400</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(NjHacI)995850000000050400</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995850000000050400</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">NjHacI</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="c">NjHacl</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RC280.L5</subfield><subfield code="b">.H473 2022</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">616.99436</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Hepatitis B /</subfield><subfield code="c">Luis Rodrigo, editor.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">London :</subfield><subfield code="b">IntechOpen,</subfield><subfield code="c">2022.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (126 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on publisher supplied metadata and other sources.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Current pharmacologic therapies for chronic hepatitis B virus (HBV) infection allow viral suppression and normalization of the liver enzyme alanine aminotransferase (ALT) and prevent liver disease from progressing. The currently available antiviral therapies very rarely lead to a functional cure. Thus, the future of a cure for HBV lies in triple combination therapies with concerted action on replication inhibition, antigen reduction, and immune stimulation. This book reviews the mechanisms and pathogenesis of HBV, as well as discusses current and potential future treatments.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Hepatoma.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Liver</subfield><subfield code="x">Tumors.</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">1-80355-008-2</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rodrigo, Luis,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-07-08 12:22:00 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2022-08-07 00:20:11 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&amp;portfolio_pid=5339197030004498&amp;Force_direct=true</subfield><subfield code="Z">5339197030004498</subfield><subfield code="b">Available</subfield><subfield code="8">5339197030004498</subfield></datafield></record></collection>